Autolus Therapeutics Plc (AUTL)
1.78
-0.07
(-3.78%)
USD |
NASDAQ |
Oct 02, 16:00
1.775
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics Profit Margin (Quarterly) : -85.60% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -85.60% |
| March 31, 2026 | -273.1% |
| December 31, 2025 | -371.9% |
| September 30, 2025 | -373.3% |
| June 30, 2025 | -229.0% |
| March 31, 2025 | -781.1% |
| December 31, 2024 | -95.30K% |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | -522.1% |
| Date | Value |
|---|---|
| December 31, 2023 | |
| September 30, 2023 | -11.29K% |
| June 30, 2023 | |
| March 31, 2023 | -3.08K% |
| December 31, 2022 | -704.6% |
| September 30, 2022 | -1.81K% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -2.76K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Bicycle Therapeutics Plc | -8.00K% |
| argenx SE | -- |
| Evaxion AS | -- |
| DBV Technologies SA | -- |
| Cellectis SA | -417.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -143.5% |
| Return on Assets | -46.70% |
| Return on Invested Capital | -51.71% |
| Gross Profit Margin (Quarterly) | 55.20% |
| Operating Margin (Quarterly) | -95.95% |
| Return on Net Operating Assets | -123.0% |